跳至主要内容
临床试验/NCT03575390
NCT03575390已完成不适用

The Beneficial Effects of Pomegranate on Hearing of Patients Without Hemodialysis: A Prospective, Randomized, Double-blinded Clinical Trial

Dalin Tzu Chi General Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年3月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Pure tone audiometry (PTA)

研究概览

简要总结

Pomegranate has anti-oxidative capacity. It might reduce symptoms of Alzheimer's disease, Drug-induced hepatitis, and might prevent deterioration of cardiovascular diseases and cancer progression. But, the beneficial effects of pomegranate on hearing impairment was still unclear.

This study aimed to investigate the beneficial effects of pomegranate on hearing impairment by a prospective, randomized, double-blinded clinical trial design. The investigators'll include 120 elderly patients without hemodialysis in our hospital, and divided them into 2 groups. Control group will receive placebo treatment; pomegranate group will receive oral pomegranate (500 mg, twice per day).

All patients received the above treatment for 9 months, and underwent pure tone audiometry and word discrimination scores before the start of the clinical trial and at the end of the treatment (9th month).

详细描述

Pomegranate has anti-oxidative capacity. It might reduce symptoms of Alzheimer's disease, Drug-induced hepatitis, and might prevent deterioration of cardiovascular diseases and cancer progression. But, the beneficial effects of pomegranate on hearing impairment was still unclear.

This study aimed to investigate the beneficial effects of pomegranate on hearing impairment by a prospective, randomized, double-blinded clinical trial design. The investigators'll include 120 elderly patients without hemodialysis in our hospital, and divided them into 2 groups. Control group will receive placebo treatment; pomegranate group will receive oral pomegranate (500 mg, twice per day).

All patients received the above treatment for 9 months, and underwent pure tone audiometry and word discrimination scores before the start of the clinical trial and at the end of the treatment (9th month).

<background> Age-related hearing impairment (ARHI) was very common in the elderly. Hearing deteriorated not only due to problems with the peripheral hearing organs, but also because of degeneration of the central auditory system. In general, peripheral hearing deteriorates more quickly and severely in male subjects than in female subjects, more severely at higher than low frequencies, and more quickly in the central auditory system than the peripheral hearing organs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 50 to 80 years old.
  • •non-renal dialysis patients.

排除标准

  • •Life can not take care of themselves or the bed of a patient.
  • •dialysis patients.
  • •Patients who can not understand the details of this study or are unable to cooperate with the examination.
  • •history of alcohol or drug abuse.
  • •history of high environmental noise exposure.
  • •The pure tone hearing threshold is greater than 10 decibel (dB), and the audiogram 4 kilohertz (kHz) air conduction threshold is greater than 8 kilohertz (kHz) air threshold value of 20 decibel (dB).

研究组 & 干预措施

control group

Placebo Comparator

Control group will receive placebo medication therapy

干预措施: Placebo (Dietary Supplement)

test group

Experimental

pomegranate group will receive oral pomegranate (500 mg, twice per day)

干预措施: Pomegranate (Dietary Supplement)

结局指标

主要结局

Pure tone audiometry (PTA)

时间窗: 9 months

pure tone thresholds of 250, 500, 1000, 2000, 4000, 8000 Hz were measured.

次要结局

  • speech discrimination score (SDS)(9 months)
  • speech reception threshold (SRT)(9 months)

研究者

发起方
Dalin Tzu Chi General Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验